Spotlight on: Recent trials in osteosarcoma and their implications for future studies
This grandround gives a succinct overview of the management of a cancer most oncologists will come across only rarely. Specialist Stefan Bielack looks at the factors that are important for personalising therapies to maximise survival rates while avoiding unnecessary limb amputations. He explores what needs to be done to improve the prognosis in this disease, where survival rates have not changed since the early 1980s.
You can read the full article in Cancer World.